XML 48 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenues (Tables)
12 Months Ended
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue The following table presents sales by operating segment disaggregated based on type of product and geographic region for the years ended December 31, 2018, 2017 and 2016.
 
Year Ended December 31, 2018
 
Year Ended December 31, 2017
 
Year Ended December 31, 2016
 
United States
 
International
 
Total
 
United States
 
International
 
Total
 
United States
 
International
 
Total
Cardiovascular
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stand-alone devices
$
202,129

 
$
159,484

 
$
361,613

 
$
148,620

 
$
126,836

 
$
275,456

 
$
105,250

 
$
85,877

 
$
191,127

Cianna Medical
6,292

 

 
6,292

 

 

 

 

 

 

Custom kits and procedure trays
92,975

 
41,781

 
134,756

 
92,474

 
33,615

 
126,089

 
93,109

 
26,138

 
119,247

Inflation devices
31,717

 
60,702

 
92,419

 
31,848

 
48,027

 
79,875

 
35,506

 
38,410

 
73,916

Catheters
68,708

 
86,817

 
155,525

 
62,284

 
65,463

 
127,747

 
56,899

 
56,468

 
113,367

Embolization devices
20,433

 
29,605

 
50,038

 
22,374

 
27,158

 
49,532

 
24,075

 
21,960

 
46,035

CRM/EP
41,970

 
6,864

 
48,834

 
36,746

 
5,168

 
41,914

 
32,561

 
3,898

 
36,459

Total
464,224

 
385,253

 
849,477

 
394,346

 
306,267

 
700,613

 
347,400

 
232,751

 
580,151

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Endoscopy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Endoscopy devices
32,189

 
1,087

 
33,276

 
26,357

 
882

 
27,239

 
22,950

 
737

 
23,687

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
$
496,413

 
$
386,340

 
$
882,753

 
$
420,703

 
$
307,149

 
$
727,852

 
$
370,350

 
$
233,488

 
$
603,838

Note: Certain revenue categories for 2017 and 2016 have been adjusted from prior disclosures to reflect changes in product classifications to be consistent with updates in management of our product portfolios during 2018. Also note that Cianna Medical is a new category in 2018 as a result of the acquisition in November 2018 (see Note 3).